ELITE 2019 Launch Expert Sally Collins of Alexion Pharmaceuticals, Inc.

Sally Collins

Senior Director, U.S. Marketing

Alexion Pharmaceuticals, Inc.

Leading a Rare Launch

When Alexion Pharmaceuticals was preparing to launch a new treatment for adult patients with paroxysmal nocturnal hemoglobinuria (PNH), Sally Collins stepped up to the challenge. PNH is an ultra-rare, life-threatening blood disorder in which uncontrolled activation of the complement system, a component of the normal immune system, results in chronic hemolysis. Sally’s proven expertise and decisive leadership style coupled with Alexion’s deep understanding of the complement system enabled Sally’s cross-functional core team to develop a comprehensive plan for a condition where patients have incredibly unique needs.

Decisiveness carries added value in the rare disease market, where stakes are high for conditions that are seldom known, let alone fully understood. Sally’s extensive experience in the rare disease space allowed her to create an informed and impactful launch plan that effectively communicated the treatment benefits of the new therapy to PNH patients and their stakeholders. She maintains the highest standards for herself and her teams through clear and assertive goals, while always keeping Alexion’s mission top of mind—serving patients.

Sally’s ability to talk to individuals on an intimate level allows her to have productive one-on-one conversations with colleagues while at the same time encouraging collaboration as a team to generate ideas and increase motivation. She also understands the value of building strong partnerships outside of her team with colleagues in the legal, compliance, and medical departments, and never fails to express her gratitude when they go above and beyond to support her. She uses the power of human connection to rally a large group toward a common goal and takes the time to recognize and celebrate their collective achievements and success.

Sally’s impressive background is a reflection of her ceaseless dedication to bringing new medicines to patients. She has held a variety of commercial roles in the industry including sales, sales leadership, marketing and key account management, with experience in both the U.S. and European markets.

Alexion Pharmaceuticals is focused on serving patients and families affected by rare diseases, and Sally embodies the persistence and dedication required to successfully launch new and innovative therapies for patients most in need.


You May Also Like

PM360 2020 Trailblazer Awards Consumer Website/Online Initiative Winner Sanofi Genzyme, Regeneron Pharmaceuticals, and MicroMass Communications, Inc.

Atopic Dermatitis Web Experience (Sanofi Genzyme, Regeneron Pharmaceuticals, MicroMass Communications, Inc.) The CRM branded ...

ELITE 2020 Disrupter Matt Giegerich of The Inception Company

Matt Giegerich CEO The Inception Company A New Way to Conduct Virtual Meetings Matt ...

Industry Briefs

Klick Health Wins Supernova Award Winning in the category of Technology Optimization and Innovation, ...